Zentek 和 Medwell 结成联盟，利用 ZenGUARD™ 增强型外科口罩彻底改变医疗保健

Zentek Ltd. 和 Medwell Solutions LLC 已签署了一份在美国经销 ZenGUARD 增强型外科口罩的最终经销协议。该协议自 2024 年 3 月 18 日起生效，有效期为 FDA 市场批准后的两年。 Medwell Solutions 是一家总部位于达拉斯的制造商和分销商，专门生产医疗保健产品，并因其在该领域的质量和经验而受到认可。 Zentek 的 ZenGUARD 技术提高了口罩的病毒过滤效率，此次合作符合 Zentek 扩大市场覆盖范围的目标。

Zentek and Medwell Forge a Strategic Alliance to Revolutionize the U.S. Healthcare Industry with ZenGUARD™ Enhanced Surgical Masks

Zentek 和 Medwell 结成战略联盟，利用 ZenGUARD™ 增强型外科口罩彻底改变美国医疗保健行业

GUELPH, ONTARIO, CANADA – March 18, 2024 – Zentek Ltd. (TSX: ZTEK), a trailblazing intellectual property development and commercialization enterprise, proudly announces a groundbreaking distribution agreement with Medwell Solutions LLC, a renowned Dallas-based healthcare product distributor. This partnership will propel the distribution of Zentek's revolutionary ZenGUARD™ Enhanced Surgical Masks throughout the vast healthcare landscape of the United States. Effective March 18, 2024, this two-year agreement will commence upon FDA market clearance.

加拿大安大略省圭尔夫 – 2024 年 3 月 18 日 – 开拓性知识产权开发和商业化企业 Zentek Ltd.（多伦多证券交易所股票代码：ZTEK）自豪地宣布与达拉斯著名医疗保健产品分销商 Medwell Solutions LLC 达成突破性分销协议。此次合作将推动 Zentek 革命性的 ZenGUARD™ 增强型外科口罩在美国广大医疗保健领域的分销。该为期两年的协议将于 FDA 市场批准后开始生效，自 2024 年 3 月 18 日起生效。

A Synergy of Expertise: Empowering Healthcare Professionals

专业知识的协同作用：赋予医疗保健专业人员权力

Medwell Solutions, a pillar of the healthcare industry, has established an unparalleled reputation for delivering exceptional products and services to healthcare facilities. Their comprehensive portfolio encompasses surgical devices, patient care supplies, and other essential consumables. With a proven track record spanning over two decades, Medwell's leadership has garnered extensive expertise in surgical technology and hospital supply chain management.

Medwell Solutions 是医疗保健行业的支柱，在为医疗保健机构提供卓越的产品和服务方面建立了无与伦比的声誉。他们全面的产品组合包括手术设备、患者护理用品和其他基本消耗品。凭借二十多年的良好业绩记录，梅德韦尔的领导能力在外科技术和医院供应链管理方面积累了广泛的专业知识。

Zentek, the visionary behind ZenGUARD™ technology, has engineered a breakthrough solution to enhance the efficacy of face masks and HVAC systems in filtering viruses. Their state-of-the-art production facility in Guelph, Ontario, has earned ISO 13485:2016 certification, a testament to their unwavering commitment to medical device quality management systems.

ZenGUARD™ 技术背后的远见者 Zentek 设计了一种突破性的解决方案，以增强口罩和 HVAC 系统过滤病毒的功效。他们位于安大略省圭尔夫市的最先进的生产设施已获得 ISO 13485:2016 认证，证明了他们对医疗器械质量管理体系的坚定承诺。

Market Expansion and Supplier Diversity

市场扩张和供应商多元化

This strategic partnership aligns seamlessly with Zentek's overarching goal of expanding its market reach. By leveraging Medwell's extensive distribution network and diverse supplier certifications, Zentek aims to make ZenGUARD™ masks readily accessible to healthcare professionals across the nation.

这一战略合作伙伴关系与 Zentek 扩大市场覆盖范围的总体目标完美契合。通过利用 Medwell 广泛的分销网络和多元化的供应商认证，Zentek 的目标是让全国的医疗保健专业人员可以轻松获得 ZenGUARD™ 口罩。

Executive Perspectives: A Shared Vision

高管视角：共同愿景

Greg Fenton, CEO of Zentek, expressed unwavering confidence in the potential of this partnership: "Medwell's established sales channels and deep understanding of the healthcare market make them an ideal partner for the distribution of ZenGUARD™ masks. We are confident that their expertise will enable us to reach a broader audience and make a significant impact on the lives of healthcare professionals."

Zentek 首席执行官 Greg Fenton 对此次合作的潜力表达了坚定的信心：“Medwell 成熟的销售渠道和对医疗保健市场的深入了解使他们成为 ZenGUARD™ 口罩分销的理想合作伙伴。我们相信，他们的专业知识将使我们将覆盖更广泛的受众并对医疗保健专业人员的生活产生重大影响。”

Keith J. Palmer, CEO of Medwell, echoed this enthusiasm: "We are thrilled to partner with Zentek and introduce ZenGUARD™ masks to the U.S. healthcare market. Their innovative technology aligns perfectly with our mission of providing cutting-edge solutions to healthcare providers. We believe that ZenGUARD™ masks have the potential to transform the industry, enhancing protection and improving patient outcomes."

Medwell 首席执行官 Keith J. Palmer 也表达了这种热情：“我们很高兴与 Zentek 合作，将 ZenGUARD™ 口罩引入美国医疗保健市场。他们的创新技术与我们为医疗保健提供者提供尖端解决方案的使命完美契合。我们相信 ZenGUARD™ 口罩有潜力改变行业，增强保护并改善患者的治疗效果。”

Financial Insights: Assessing Zentek's Market Position

财务洞察：评估 Zentek 的市场地位

As Zentek embarks on this pivotal distribution agreement, investors and industry observers are closely scrutinizing the company's financial health and market performance.

随着 Zentek 着手签署这一关键分销协议，投资者和行业观察家正在密切关注该公司的财务状况和市场表现。

• Market Capitalization (Adjusted): As of today, Zentek's market capitalization stands at $120.39 million USD.
• P/E Ratio (Adjusted): The company's price-to-earnings ratio, based on the last twelve months leading up to Q3 2024, is currently -13.79, indicating that it is not currently generating profits.
• Revenue Growth: Over the same period, Zentek has experienced a significant decline in revenue, with a -85.06% change as of Q3 2024.

InvestingPro Tips: Unlocking Zentek's Potential

市值（调整后）：截至今日，Zentek 的市值为 1.2039 亿美元。 市盈率（调整后）：该公司的市盈率基于截至 2024 年第三季度的过去 12 个月，目前为-13.79，表明目前尚未产生利润。收入增长：同期，Zentek 收入大幅下降，截至 2024 年第三季度，变化为-85.06%。InvestingPro 提示：释放 Zentek 潜力

Analysts at InvestingPro, a leading financial insights platform, offer valuable insights into Zentek's market positioning and competitive edge:

领先的金融洞察平台 InvestingPro 的分析师对 Zentek 的市场定位和竞争优势提供了宝贵的见解：

• Industry Niche Positioning: Zentek operates as a niche player in its industry, which could impact its ability to gain a substantial market share.
• Financial Stability: The company's liquid assets exceed its short-term obligations, providing a degree of financial stability in managing immediate responsibilities.
• Gross Profit Margins: Zentek's weak gross profit margins, reflected in a negative -841.52% over the last twelve months as of Q3 2024, could be a cause for concern.

Investors seeking a comprehensive analysis of Zentek's financial performance can explore InvestingPro's exclusive Tips at https://www.investing.com/pro/ZTEK. These insights encompass Zentek's debt levels, valuation multiples, and historical performance.

行业利基定位：Zentek 在其行业中作为利基参与者运营，这可能会影响其获得大量市场份额的能力。财务稳定性：公司的流动资产超过其短期债务，在管理直接责任方面提供一定程度的财务稳定性毛利率：Zentek 的毛利率疲软，截至 2024 年第三季度的过去 12 个月为负 -841.52%，可能会引起担忧。寻求对 Zentek 财务业绩进行全面分析的投资者可以在以下网址探索 InvestingPro 的独家提示： https://www.investing.com/pro/ZTEK。这些见解包括 Zentek 的债务水平、估值倍数和历史业绩。

Exclusive Offer for Enhanced Insights

增强洞察力的独家优惠

For investors seeking a deeper dive into Zentek's financial future, InvestingPro is offering an exclusive 10% off a yearly or biyearly Pro and Pro+ subscription with the coupon code PRONEWS24. This limited-time offer provides access to an enhanced toolset for making informed investment decisions.

对于寻求更深入了解 Zentek 财务未来的投资者，InvestingPro 提供每年或每两年一次的 Pro 和 Pro+ 订阅独家 10% 折扣，优惠券代码为 PRONEWS24。通过此限时优惠，您可以访问增强的工具集，以做出明智的投资决策。

Conclusion: A Transformative Partnership

结论：变革性的伙伴关系

The distribution agreement between Zentek and Medwell Solutions represents a pivotal moment for the healthcare industry. ZenGUARD™ Enhanced Surgical Masks, empowered by Zentek's innovative technology, are poised to revolutionize infection prevention practices, benefiting healthcare professionals and patients alike. This partnership will undoubtedly reshape the healthcare landscape, highlighting the power of collaboration in driving innovation and enhancing patient outcomes.

Zentek 和 Medwell Solutions 之间的分销协议代表着医疗保健行业的关键时刻。 ZenGUARD™ 增强型外科口罩由 Zentek 的创新技术提供支持，有望彻底改变感染预防实践，使医疗保健专业人员和患者受益。这种伙伴关系无疑将重塑医疗保健格局，凸显合作在推动创新和改善患者治疗效果方面的力量。